SGLT2 Inhibitors in the Early Treatment of Type 2 DiabetesSGLT2 Inhibitors in the Early Treatment of Type 2 Diabetes

While SGLT2 inhibitors have been targeted at patients with long-standing type 2 diabetes, could they also offer significant benefit in early management? International Journal of Clinical Practice
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news